Nanocarrier-based dermopharmaceutical formulations for the topical management of atopic dermatitis

纳米载体 特应性皮炎 固体脂质纳米粒 医学 不利影响 脂质体 生物利用度 耐受性 药品 药物输送 皮肤病科 药理学 纳米技术 材料科学
作者
Ana Cláudia Paiva‐Santos,Melissa Gama,Diana Peixoto,Inês Sousa-Oliveira,Inês Ferreira-Faria,Mahdi Zeinali,Soheil Abbaspour‐Ravasjani,Filipa Mascarenhas-Melo,Hamed Hamishehkar,Francisco Veiga
出处
期刊:International Journal of Pharmaceutics [Elsevier BV]
卷期号:618: 121656-121656 被引量:30
标识
DOI:10.1016/j.ijpharm.2022.121656
摘要

Atopic dermatitis (AD) is a chronic disease that affects the skin, and that is characterized by highly itchy inflammation, frequent eczematous lesions, and a fluctuating course. The current treatment consists of a multi-stage approach that aims to establish persistent disease control towards the improvement of the quality of life of the patients. Topical therapy is the basis of AD treatment, however, due to the difficulty of crossing the skin barrier, topical application of drugs remains a challenge. In fact, in addition to the low skin bioavailability, and limited accessibility to deeper skin of the drugs - due to difficulty in penetrating the epidermis - implemented drugs in the clinical are associated with serious adverse effects, which are responsible for safety and efficacy limitations, leading to a reduction in patients' compliance. Nanotechnology arises as an emerging approach for the treatment of AD, allowing for controlled release, targeted delivery, improved penetration, and bioavailability of drugs assets, resulting in marked improved therapeutic efficacy and reduction of adverse effects. Although its promising outputs, additional studies are needed to recognize the toxicological characteristics, cost-benefit, and long-term safety of nanocarriers applied to this end. Advanced drug delivery systems, particularly nanoemulsions, liposomes, ethosomes, transfersomes, solid lipid nanoparticles, nanostructured lipid carriers, nanocrystals, polymeric nanoparticles, and polymeric micelles have been used, and are thoroughly addressed in this review as promising nanoformulations towards the topical treatment of AD.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
PanCiro发布了新的文献求助10
4秒前
kmzzy发布了新的文献求助10
4秒前
5秒前
无情莆发布了新的文献求助10
5秒前
洪亮完成签到,获得积分0
6秒前
8秒前
听风完成签到,获得积分10
8秒前
9秒前
Akim应助一吃一大碗采纳,获得10
10秒前
bkagyin应助PanCiro采纳,获得10
10秒前
灰灰12138发布了新的文献求助10
11秒前
13秒前
13秒前
ENO_i完成签到,获得积分10
14秒前
搜集达人应助邓权采纳,获得10
15秒前
16秒前
ENO_i发布了新的文献求助10
18秒前
18秒前
18秒前
脑洞疼应助蹦蹦采纳,获得10
18秒前
callmecjh发布了新的文献求助10
19秒前
19秒前
hzb完成签到 ,获得积分20
21秒前
相龙发布了新的文献求助30
21秒前
ywang发布了新的文献求助10
22秒前
24秒前
科研通AI5应助陈骏康采纳,获得10
25秒前
clarkq发布了新的文献求助10
25秒前
guozizi应助gfbh采纳,获得200
26秒前
科研通AI2S应助邓权采纳,获得10
27秒前
相龙完成签到,获得积分10
27秒前
史小霜发布了新的文献求助10
28秒前
无花果应助骑驴找马采纳,获得10
31秒前
32秒前
风起莫云扬完成签到 ,获得积分10
32秒前
33秒前
Mike完成签到,获得积分20
33秒前
彭于晏应助科研通管家采纳,获得10
34秒前
wu8577应助科研通管家采纳,获得10
35秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Picture Books with Same-sex Parented Families: Unintentional Censorship 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
A Preliminary Study on Correlation Between Independent Components of Facial Thermal Images and Subjective Assessment of Chronic Stress 500
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3971516
求助须知:如何正确求助?哪些是违规求助? 3516229
关于积分的说明 11181488
捐赠科研通 3251405
什么是DOI,文献DOI怎么找? 1795821
邀请新用户注册赠送积分活动 876051
科研通“疑难数据库(出版商)”最低求助积分说明 805245